## **Core Concept**
The question tests knowledge of anesthetic management in patients with asthma, focusing on the choice of induction agent. Asthma is a chronic inflammatory disease of the airways characterized by episodic airflow obstruction. The ideal induction agent in asthma should not trigger bronchospasm.

## **Why the Correct Answer is Right**
Propofol () is the correct answer because it has a bronchodilatory effect, making it suitable for patients with asthma. Propofol decreases airway resistance and has a direct relaxant effect on bronchial smooth muscle. It also depresses the cough reflex, which is beneficial during intubation.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Ketamine () can cause an increase in salivation and has a potential to induce laryngospasm, which is undesirable in asthma patients. Although it has bronchodilatory properties, its side effects make it less ideal compared to propofol.
* **Option B:** Etomidate () is not commonly associated with significant bronchodilation and may cause adrenal suppression with repeated doses, which is not directly relevant but makes propofol more favorable.
* **Option D:** Thiopentone () can induce histamine release, potentially leading to bronchospasm, making it less suitable for patients with asthma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that propofol is often considered the induction agent of choice in patients with asthma due to its favorable profile of not causing significant histamine release or respiratory depression initially, and having a bronchodilatory effect.

## **Correct Answer:** . Propofol